The P4 Precision Medicine Accelerator programme is led by Professor Phil Beales, Chair of the UCL Institute of Precision Medicine, Professor of Medical and Molecular Genetics at the UCL Great Ormond Street Institute of Child Health and UCLPartners. The delivery of precision medicine requires several sectors (academia, healthcare and industry) work together. It is the programme's mission to facilitate new and innovative collaborations with academia, industry and healthcare.
UCL have partnered with Capital Enterprise, a body of connectors, influencers, investors and policy-makers, collaborating to serve and super-charge London’s start-up scene.
The P4 programme creates a new and unique ecosystem to facilitate the scale and adoption of precision medicine SMEs by providing access to unparalleled expertise in genomic profiling, drug targeting, disease marker discovery, diagnostics/companion diagnostics, clinical trials design and delivery, software development, engineering, artificial intelligence, regulatory compliance and health data. Cross-faculty support led by the UCL Institute for Precision Medicine, leverages the talent pool of academics at UCL and its partners. Capital Enterprise has experience of supporting and scaling tech SMEs and providing access to unique funding streams to ensure SMEs thrive.
The Programme is a 6-12 month scale up programme (depending on stage), connecting you with academia, industry and the healthcare sectors to create a clear innovation pathway.
To gain the full benefit from this programme, it’s advised that companies:
- Work in the area of Precision Medicine*
- Be early- to mid-stage medical device, diagnostic, or digital health companies
- Not yet closed a Series B
- Be data-driven
- Be able to demonstrate their route to market with a time-frame of 12 – 18 months
- Have already received seed/grant funding
- Show team credibility (at least 3 members with complimentary and relevant expertise)
- Have Data Scientist involvement
- Use of AI